These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 24919224)

  • 21. TM6SF2: catch-22 in the fight against nonalcoholic fatty liver disease and cardiovascular disease?
    Kahali B; Liu YL; Daly AK; Day CP; Anstee QM; Speliotes EK
    Gastroenterology; 2015 Apr; 148(4):679-84. PubMed ID: 25639710
    [No Abstract]   [Full Text] [Related]  

  • 22. NASH, from diagnosis to treatment: Where do we stand?
    Harrison SA
    Hepatology; 2015 Dec; 62(6):1652-5. PubMed ID: 26446314
    [No Abstract]   [Full Text] [Related]  

  • 23. An analysis of polygenic risk scores for non-alcoholic fatty liver disease.
    Jun DW
    Clin Mol Hepatol; 2021 Jul; 27(3):446-447. PubMed ID: 34024056
    [No Abstract]   [Full Text] [Related]  

  • 24. Alcoholic and Nonalcoholic Liver Disease: Diagnostic Assessment and Therapeutic Perspectives.
    Gitto S; Bihl F; Schepis F; Caputo F; Berenguer M
    Biomed Res Int; 2019; 2019():8691502. PubMed ID: 31380439
    [No Abstract]   [Full Text] [Related]  

  • 25. [Non-alcoholic fatty liver disease. Role of primary care physicians].
    Caballeria J; Caballeria L
    Med Clin (Barc); 2015 Aug; 145(3):112-4. PubMed ID: 26004277
    [No Abstract]   [Full Text] [Related]  

  • 26. [Diagnosis and treatment of non-alcoholic fatty liver disease].
    Su W; Cao H; Fan J
    Zhonghua Gan Zang Bing Za Zhi; 2014 Sep; 22(9):705-7. PubMed ID: 25647847
    [No Abstract]   [Full Text] [Related]  

  • 27. Nonalcoholic Fatty Liver Disease.
    Gaglio PJ
    Clin Liver Dis; 2016 May; 20(2):xiii-xiv. PubMed ID: 27063278
    [No Abstract]   [Full Text] [Related]  

  • 28. KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease.
    Kang SH; Lee HW; Yoo JJ; Cho Y; Kim SU; Lee TH; Jang BK; Kim SG; Ahn SB; Kim H; Jun DW; Choi JI; Song DS; Kim W; Jeong SW; Kim MY; Koh H; Jeong S; Lee JW; Cho YK;
    Clin Mol Hepatol; 2021 Jul; 27(3):363-401. PubMed ID: 34154309
    [No Abstract]   [Full Text] [Related]  

  • 29. Pathological features of fatty liver disease.
    Yeh MM; Brunt EM
    Gastroenterology; 2014 Oct; 147(4):754-64. PubMed ID: 25109884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Relationship between normal serum uric acid levels and nonalcoholic fatty liver disease in postmenopausal women].
    Liu P; Ma F; Lou H; Zhu Y; Chen Y
    Zhonghua Gan Zang Bing Za Zhi; 2014 Jan; 22(1):53-7. PubMed ID: 24721245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Interview with PD Dr. Anton Gillessen, Münster. Non-alcoholic fatty liver: change in the life style!].
    Gillessen A
    MMW Fortschr Med; 2015 Jan; 157(1):69. PubMed ID: 25767868
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical utility of polygenic risk scores for predicting NAFLD disorders.
    Dessein A
    J Hepatol; 2021 Apr; 74(4):769-770. PubMed ID: 33653592
    [No Abstract]   [Full Text] [Related]  

  • 33. In reply.
    Weiß J; Rau M; Geier A
    Dtsch Arztebl Int; 2015 Feb; 112(9):144. PubMed ID: 25797510
    [No Abstract]   [Full Text] [Related]  

  • 34. Mediterranean diet.
    Hofmeister M
    Dtsch Arztebl Int; 2015 Feb; 112(9):143. PubMed ID: 25797508
    [No Abstract]   [Full Text] [Related]  

  • 35. Difficult-to-understand point.
    Hofmann W
    Dtsch Arztebl Int; 2015 Feb; 112(9):143. PubMed ID: 25797507
    [No Abstract]   [Full Text] [Related]  

  • 36. Benefit: "therapeutic indication".
    Walle H
    Dtsch Arztebl Int; 2015 Feb; 112(9):143-4. PubMed ID: 25797509
    [No Abstract]   [Full Text] [Related]  

  • 37. MRI, CT scan, and ultrasound in the diagnosis of nonalcoholic fatty liver disease.
    Noureddin M; Khoyilar C; Palmer SL
    J Clin Gastroenterol; 2015 Apr; 49(4):351-2. PubMed ID: 25551206
    [No Abstract]   [Full Text] [Related]  

  • 38. [Prospective cohort study of the predictive value of hemoglobin levels for non-alcoholic fatty liver disease].
    Cai W; Zhang B; Miao L; Wang T; Zou Y; Li Y; Yao H
    Zhonghua Gan Zang Bing Za Zhi; 2014 Mar; 22(3):200-4. PubMed ID: 24824122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prevalence of nonalcoholic fatty liver disease in Asia].
    Zhang W; Wei L
    Zhonghua Gan Zang Bing Za Zhi; 2013 Nov; 21(11):801-4. PubMed ID: 24516923
    [No Abstract]   [Full Text] [Related]  

  • 40. [Fructose as a risk factor nonalcoholic fatty liver disease].
    Yi C; Li Y
    Zhonghua Gan Zang Bing Za Zhi; 2014 May; 22(5):383-5. PubMed ID: 25222975
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.